Interleukin 6, tumor necrosis factor α and their soluble receptors in the blood serum of patients with denture stomatitis and fungal infection

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 2, 2000, Pages 101-105

  Pietruski, Jan Krzysztof ^a   Pietruska, Małgorzata Dorota ^a   Jabłońska, Ewa ^a   Sacha, Pawel ^a   Zaremba, Maria ^a   Stokowska, Wanda ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Denture stomatitis; Fungal infection; Interleukin 6; Soluble receptors; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MYCOSIS; STOMATITIS; THRUSH;

ADULT; CANDIDIASIS, ORAL; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYCOSES; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR; STOMATITIS, DENTURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0039840321     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ADERKA D., LE J. and VILCEK J. (1989): IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol., 143, 3517-3523.
2. BARRERA P., BOERBOOMS A. M., JANSEN E. M., SAUERWEIN R. W., GALLATI H., MULDER J., DE BOO T., DEMACKER P. N., VAN DE PUTTE L. B. and VAN DER MEER J. W. (1993): Circulating soluble tumor necrotic factor receptors, interleukin 2 receptors, tumor necrotic factor alpha and interleukin 6 levels in rheumatoid arthritis. Arthritis Reum., 36, 1070-1079.
3. BEMELMANS M. H., GOUMA D. J. and BUURMAN W. A. (1993): LPS-induced sTNF receptor release in vivo a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma. J. Immunol., 151, 5554-5562.
4. BLASI E., PITZURRA L., PULITI M., MAZZOLLA R., BARLUZZI R., SALEPPICO S. and BISTONI F. (1994): Different events involved in the induction of macrophage tumor necrosis factor by Candida albicans and lipopolysaccharide. Cell. Immunol., 157, 501-509.
5. CENCI E., MENCACCI A., SPACCAPELO R., TONETTI L., MOSCI P., ENSSLE K. H., PUCCETTI P., ROMANI L. and BISTONI F. (1995): T helper cell type 1 (Th1) - and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Thl development. J. Infect. Dis., 171, 1279-1288.
6. CICCO N. A., LINDEMANN A., CONTENT J., VANDENBUSSCHE P., LUBBERT M., GAUSS J., MERTELSMANN R. and HERRMANN F. (1990): Inducible production of interleukin-6 by human polymorphonuclear neutrophils: Role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood, 75, 2049-2052.
7. COPE A. P., ADERKA D., WALLACH D., KAHAN M., CHU N. R., BRENNAN F. M. and FELDMAN M. (1995): Soluble TNF receptor production by activated T lymphocytes differential effects of acute and chronic exposure to TNF. Immunology, 84, 21-30.
8. DOMER J. E., GARNER R. E. and BEFIDI-MENGUE R. N. (1989): Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect. Immun., 57, 693-700.
9. DURANDY A., FISCHER A., LE DEIST F., DROUHET E. and GRISCELLI C. (1987): Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis. J. Clin. Immunol., 7, 400-409.
10. FERRANTE A. (1989): Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun., 57, 2115-2122.
11. FISCHER A., BALLET J. J. and GRISCELLI C. (1978): Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic: mucocutaneous candidiasis. J. Clin. Invest., 62, 1005-1013.
12. IACOPINO A. M. and WATHEN W. F. (1992): Oral candidal infection and denture stomatitis: a comprehensive review. J. Am. Dent. Assoc., 123, 46-51.
13. JABŁOŃSKA E. (1997): Release of soluble IL-6 receptor (IL6sR) in comparison with release of soluble TNF receptor (sTNF-Rs) by PMNs and WBC derived from breast cancer patients. Cancer Lett., 119, 79-85.
14. JABŁOŃSKA E., PIETRUSKA Z., KOZŁOWSKI M. and FURMAN M. (1996): Serum levels of soluble interleukin-2 receptor and soluble tumor necrosis factor receptor in patients with esophageal carcinoma. Dis. Esophagus, 9, 202-205.
15. KAMINISHI H., MIYAGUCHI H., TAMAKI T., SUENAGA N., HISAMATSU M., MIHASHI I., MATSUMOTO H., MAEDA H. and HAGIHARA Y. (1995): Degradation of humoral host defence by Candida albicans proteinase. Infect. Immun., 63, 984-988.
16. LILIC D., CANT A. J., ABINUN M., CALVERT J. E. and SPICKETT G. P. (1996): Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production. Clin. Exp. Immunol., 105, 205-212.
17. MATTHEWS R. C. (1994): Pathogenicity determinants of Candida albicans: potential targets for immunotherapy? Microbiology, 140, 1505-1511.
18. MENCACCI A., TOROSANTUCCI A., SPACCAPELO R., ROMANI L., BISTONI F. and CASSONE A. (1994): A mannoprotein constituent of Candida albicans that elicites different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect. Immun., 62, 5353-5360.
19. NELSON R. D., HERRON R. T., MCCORMACK R. T. and GEHRZ R. C. (1984): Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan plysaccharide. Infect Immun., 43, 1041-1046.
20. RAMANATHAN M. (1997): A physicochemical modelling approach for estimating and stability of soluble receptor-found tumor necrosis factor-alpha. Cytokine, 9, 19-26.
21. ROBAK E., JEDRZEJEWSKA-SYSA, ROBAK T., STEPIEŃ H., WOŹNIACKA A. and WASZCZYKOWSKA E. (1996): Tumor necrotic factor alpha (TNF-alpha), interleukin 6 (IL-6) and their soluble receptors (sTNFα-Rp55 and sIL-6R) serum levels in systemic lupus erythrematosus. Mediat. Inflam., 5, 435-441.
22. ROBAK T. (1995): Biologia i farmakologia cytokin. Wydawnictwo Naukowe PWN, Warszawa-Łódź.
23. RODRIGUEZ-ARCHILLA A., URQUIA M., CUTANDO A. and ASENCIO R. (1996): Denture stomatitis. Quantification of interleukin-2 production by mononuclear blood cells cultured with Candida albicans. J. Prosthet. Dent., 75, 426-431.
24. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med., 183, 1345-1355.
25. ROMANI L., MENCACCI A., TONETTI L., SPACCAPELO R., CENCI E., PUCCETTI P., WOLF S. F. and BISTONI F. (1994): IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol., 153, 5167-5175.
26. ROMANI L., MENCACCI A., TONETTI L., SPACCAPELO R., CENCI E., WOLF S., PUCCETTI P. and BISTONI F. (1994): Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol., 24, 909-915.
27. SMITH P. D., LAMERSON C. L., BANKS S. M., SAINI S. S., WAHL L. M., CALDERONE R. A. and WAHL S. M. (1990): Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. J. Infect. Dis., 161, 999-1005.
28. SPACCAPELO R., ROMANI L., TONETTI L., CENCI E., MENCACCI A., DEL-SERO G., TOGNELLINI R., REED S. G., PUCCETTI P. and BISTONl F. (1995): TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol., 155, 1349-1360.
29. SPIECHOWICZ E. (1993): Aktualne poglady na temat stomatopatii protetycznej. Prot. Stom., 43, 67-73.
30. SPIECHOWICZ E. (1993): Stomatopatie protetyczne. PZWL Warszawa.
31. STEINSHAN S., BEMELMANS M. H., VAN TITS L. J., BERGH K., BURNMAN W. A. and WAAGE A. (1996): TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J. Immunol., 157, 2155-2159.
32. TONETTI L., SPACCAPELO R., CENCI E., MENCACCI A., PUCCETTI P., COFFMAN R. L., BISTONI F. and ROMANI L. (1995): Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol., 25, 1559-1565.
33. YAMAMOTO T., YONEDA K., UETA E., HIROTA J. and OSAKI T. (1991): Serum cytokine levels in patients with oral mucous membrane disorders. J. Oral Pathol. Med., 20, 275-279.
34. ZAREMBA M. L. and BOROWSKI J. (1994): Podstawy mikrobiologii lekarskiej. PZWL Warszawa.